Enantioselective Synthesis of PPAR (Peroxisome Proliferator-Activated Receptors) Agonists and Antagonists

被引：1

作者：

Goya, Pilar ^{[1
]}

Perez-Fernandez, Ruth ^{[1
]}

Gonzalez-Muniz, Rosario ^{[1
]}

Elguero, Jose ^{[1
]}

机构：

[1] CSIC, Inst Quim Med, E-28006 Madrid, Spain

来源：

CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2014年 / 14卷 / 10期

关键词：

PPAR; enantioselective separation; enantioselective synthesis; Evans' chiral auxiliary; asymmetric hydrogenation; chiral HPLC; chiral salts; PHENYLPROPANOIC ACID-DERIVATIVES; EFFICIENT ASYMMETRIC-SYNTHESIS; ALPHA/GAMMA DUAL AGONISTS; LIGAND-BINDING DOMAIN; BIOLOGICAL EVALUATION; ALPHA AGONIST; DESIGN; POTENCY; AGENTS;

D O I：

10.2174/1568026614666140423112822

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

This review deals with stereoselective issues in PPAR ligands some of which are in clinical use for treating certain metabolic disorders. After a short introduction of these nuclear receptor and their agonists, some cases of enantioselective separations are reported. The main part concerns stereoselective synthesis first starting with asymmetric synthesis from chiral precursors followed by what we refer to as "true" enantioselective methods. Some examples are discussed in detail for each particular heading.

引用

页码：1283 / 1293

页数：11

共 50 条

[31] Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence
Le Foll, Bernard
Di Ciano, Patricia
Panlilio, Leigh V.
Goldberg, Steven R.
Ciccocioppo, Roberto
CURRENT DRUG TARGETS, 2013, 14 (07) : 768 - 776
[32] The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases
Gao, Jianjun
Gu, Zhaoyan
FRONTIERS IN PHARMACOLOGY, 2022, 13
[33] Peroxisome Proliferator-Activated Receptors of Trophoblast Cells in Miscarriage
N. V. Alexandrova
E. A. Dubova
O. R. Baev
A. I. Shchegolev
G. T. Sukhikh
Bulletin of Experimental Biology and Medicine, 2012, 152 : 768 - 771
[34] Peroxisome Proliferator-Activated Receptors of Trophoblast Cells in Miscarriage
Alexandrova, N. V.
Dubova, E. A.
Baev, O. R.
Shchegolev, A. I.
Sukhikh, G. T.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 152 (06) : 768 - 771
[35] Design and synthesis of silicon-containing fatty acid amide derivatives as novel peroxisome proliferator-activated receptor (PPAR) agonists
Kajita, Daisuke
Nakamura, Masaharu
Matsumoto, Yotaro
Ishikawa, Minoru
Hashimoto, Yuichi
Fujii, Shinya
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (16) : 3350 - 3354
[36] Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor α agonists
Yamazaki, Yukiyoshi
Abe, Kazutoyo
Torna, Tsutornu
Nishikawa, Masahiro
Ozawa, Hidefurni
Okuda, Ayurnu
Araki, Takaaki
Odaa, Soichi
Inoue, Keisuke
Shibuya, Kimiyuki
Staels, Bart
Fruchart, Jean-Charles
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4689 - 4693
[37] Recent Updates on Peroxisome Proliferator-Activated Receptor Agonists for the Treatment of Metabolic Syndrome
Grewal, Ajmer S.
Beniwal, Meenu
Pandita, Deepti
Sekhon, Bhupinder S.
Lather, Viney
MEDICINAL CHEMISTRY, 2016, 12 (01) : 3 - 21
[38] Targeting the Tumor Stroma with Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Bundscherer, Annika
Reichle, Albrecht
Hafner, Christian
Meyer, Stefanie
Vogt, Thomas
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (07) : 816 - 821
[39] Design and synthesis of benzoxazole containing indole analogs as peroxisome proliferator-activated receptor-γ/δ dual agonists
Gim, Hyo Jin
Cheon, Ye-Jin
Ryu, Jae-Ha
Jeon, Raok
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (10) : 3057 - 3061
[40] Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone
Sakamoto, J
Kimura, H
Moriyama, S
Odaka, H
Momose, Y
Sugiyama, Y
Sawada, H
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (03) : 704 - 711

← 1 2 3 4 5 →